Journal article

Correlates of property crime in a cohort of recently released prisoners with a history of injecting drug use

Amy Kirwan, Brendan Quinn, Rebecca Winter, Stuart A Kinner, Paul Dietze, Mark Stoove

HARM REDUCTION JOURNAL | BMC | Published : 2015

Abstract

BACKGROUND: Injecting drug use (IDU) is a strong predictor of recidivism and re-incarceration in ex-prisoners. Although the links between drug use and crime are well documented, studies examining post-release criminal activity and re-incarceration risk among ex-prisoners with a history of IDU are limited. We aimed to explore factors associated with property crime among people with a history of IDU recently released from prison. METHOD: Individuals with a history of IDU released from prison within the past month were recruited via targeted and snowball sampling methods from street drug markets and services for people who inject drugs (PWID) into a 6-month cohort study. A multivariate logistic..

View full abstract

Grants

Awarded by NHMRC


Awarded by National Health and Medical Research Council (NHMRC)


Awarded by NHMRC Centre for Research Excellence on Injecting Drug Use


Funding Acknowledgements

Funding for this study was provided by Victorian Department of Health; the Victorian Department of Health had no further role in the study design; in the collection, analysis and interpretation of data; or in the writing of the report. The Department had input into the decision to submit the paper for publication. Amy Kirwan is supported by NHMRC funding for the Centre for Research Excellence into Injecting Drug Use. Stuart Kinner is supported by a Career Development Award from the National Health and Medical Research Council (NHMRC) (APP1004765). Rebecca Winter is supported by an NHMRC Postgraduate Scholarship (no. 603756) and the NHMRC Centre for Research Excellence on Injecting Drug Use (no. 1001144). Paul Dietze is supported by an ARC Future Fellowship. Paul Dietze has received united educational grant funding from Reckitt Benckiser used to conduct post-marketing surveillance of the introduction of buprenorphine-naloxone in Australia.Mark Stoove is supported by a Career Development Fellowship from the National Health and Medical Research Council (NHMRC) (APP1090445).